Ascendis Pharma A/S
ASND212.110USD
-1.130-0.53%
收盘 12/16, 16:00（美东）报价延迟15分钟
13.09B总市值
亏损市盈率 TTM
关于 Ascendis Pharma A/S 公司
Ascendis Pharma A/S is a Denmark-based company that manufactures pharmaceutical products. The Company produces products for the treatments of growth hormone deficiency, endocrinology, central nervous system disorders, infectious diseases, and diabetes. The Company operates globally though its subsidiaries: Ascendis Pharma GmbH (Germany), Ascendis Pharma, Inc. (Delaware, United States), Ascendis Pharma Endocrinology, Inc. (Delaware, United States), Ascendis Pharma, Ophthalmology Division A/S (Denmark), Ascendis Pharma, Endocrinology Division A/S (Denmark), Ascendis Pharma Bone Diseases A/S (Denmark), Ascendis Pharma Growth Disorders A/S (Denmark) and Ascendis Pharma Oncology Division A/S (Denmark).
Ascendis Pharma A/S简介
公司代码ASND
公司名称Ascendis Pharma A/S
上市日期Jan 28, 2015
CEOMoller Mikkelsen (Jan)
员工数量- -
证券类型Depository Receipt
年结日Jan 28
公司地址Tuborg Boulevard 12
城市HELLERUP
上市交易所NASDAQ OMX - NASDAQ BASIC
国家Denmark
邮编2900
电话4570222244
网址https://ascendispharma.dk/
公司代码ASND
上市日期Jan 28, 2015
CEOMoller Mikkelsen (Jan)
Ascendis Pharma A/S公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Michael Wolff Jensen
Mr. Michael Wolff Jensen
Executive Vice President, Chief Legal Officer, Member of the Executive Board
Executive Vice President, Chief Legal Officer, Member of the Executive Board
5.76K
+198.45%
Mr. Flemming Steen Jensen
Mr. Flemming Steen Jensen
Executive Vice President, Product Supply and Quality
Executive Vice President, Product Supply and Quality
1.86K
+100.43%
Mr. Lars Holtug, CPA
Mr. Lars Holtug, CPA
Independent Director
Independent Director
1.59K
+78.59%
Ms. Lisa Bright
Ms. Lisa Bright
Independent Director
Independent Director
1.09K
+178.01%
Dr. Albert Cha, M.D., Ph.D.
Dr. Albert Cha, M.D., Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
1.09K
+178.01%
Ms. Siham Imani
Ms. Siham Imani
Independent Director
Independent Director
364.00
--
Mr. Mads Bodenhoff
Mr. Mads Bodenhoff
Senior Vice President, Head of Finance and Principal Accounting Officer
Senior Vice President, Head of Finance and Principal Accounting Officer
193.00
--
Mr. Donovan (Jay) Wu
Mr. Donovan (Jay) Wu
Executive Vice President, U.S. President
Executive Vice President, U.S. President
--
--
Dr. Aimee Shu,, M.D.
Dr. Aimee Shu,, M.D.
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
--
--
Mr. William Carl (Bill) Fairey, Jr.
Mr. William Carl (Bill) Fairey, Jr.
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Michael Wolff Jensen
Mr. Michael Wolff Jensen
Executive Vice President, Chief Legal Officer, Member of the Executive Board
Executive Vice President, Chief Legal Officer, Member of the Executive Board
5.76K
+198.45%
Mr. Flemming Steen Jensen
Mr. Flemming Steen Jensen
Executive Vice President, Product Supply and Quality
Executive Vice President, Product Supply and Quality
1.86K
+100.43%
Mr. Lars Holtug, CPA
Mr. Lars Holtug, CPA
Independent Director
Independent Director
1.59K
+78.59%
Ms. Lisa Bright
Ms. Lisa Bright
Independent Director
Independent Director
1.09K
+178.01%
Dr. Albert Cha, M.D., Ph.D.
Dr. Albert Cha, M.D., Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
1.09K
+178.01%
Ms. Siham Imani
Ms. Siham Imani
Independent Director
Independent Director
364.00
--
收入明细
单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Commercial sale of products
153.66M
97.23%
Rendering of services
3.57M
2.26%
License
812.00K
0.51%
地区USD
名称
营收
占比
North America
108.45M
68.62%
Europe
27.89M
17.65%
Rest of world
21.70M
13.73%
业务
地区
业务USD
名称
营收
占比
Commercial sale of products
153.66M
97.23%
Rendering of services
3.57M
2.26%
License
812.00K
0.51%
股东统计
更新时间: 12月4日 周四
更新时间: 12月4日 周四
持股股东
股东类型
持股股东
持股股东
占比
RA Capital Management, LP
16.66%
Westfield Capital Management Company, L.P.
8.53%
Avoro Capital Advisors LLC
8.28%
Janus Henderson Investors
7.01%
Fidelity Management & Research Company LLC
6.68%
其他
52.84%
持股股东
持股股东
占比
RA Capital Management, LP
16.66%
Westfield Capital Management Company, L.P.
8.53%
Avoro Capital Advisors LLC
8.28%
Janus Henderson Investors
7.01%
Fidelity Management & Research Company LLC
6.68%
其他
52.84%
股东类型
持股股东
占比
Investment Advisor/Hedge Fund
43.51%
Investment Advisor
36.00%
Venture Capital
16.92%
Hedge Fund
4.61%
Research Firm
2.38%
Private Equity
2.29%
Individual Investor
0.76%
Pension Fund
0.36%
Bank and Trust
0.01%
机构持股
更新时间: 12月8日 周一
更新时间: 12月8日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q4
523
68.62M
116.45%
+3.30K
2025Q3
540
68.73M
112.39%
+4.25M
2025Q2
515
64.43M
118.51%
-2.60M
2025Q1
495
67.05M
117.13%
-3.67M
2024Q4
471
65.26M
121.58%
+1.14M
2024Q3
461
64.02M
116.74%
+1.57M
2024Q2
446
62.31M
123.50%
-4.72K
2024Q1
440
62.32M
122.74%
-9.15M
2023Q4
415
61.74M
123.84%
-59.49K
2023Q3
401
61.90M
129.48%
-512.07K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
RA Capital Management, LP
10.28M
16.88%
--
--
Jun 30, 2025
Westfield Capital Management Company, L.P.
5.45M
8.95%
-27.86K
-0.51%
Jun 30, 2025
Avoro Capital Advisors LLC
4.98M
8.18%
-238.00K
-4.56%
Jun 30, 2025
Janus Henderson Investors
4.43M
7.27%
-59.16K
-1.32%
Jun 30, 2025
Fidelity Management & Research Company LLC
4.18M
6.86%
-125.41K
-2.91%
Jun 30, 2025
Artisan Partners Limited Partnership
3.99M
6.55%
-266.20K
-6.25%
Jun 30, 2025
Capital International Investors
3.05M
5%
+172.14K
+5.99%
Jun 30, 2025
T. Rowe Price Investment Management, Inc.
3.58M
5.88%
+529.72K
+17.35%
Jun 30, 2025
MFS Investment Management
1.90M
3.11%
+23.62K
+1.26%
Jun 30, 2025
Wellington Management Company, LLP
918.10K
1.51%
+330.33K
+56.20%
Jun 30, 2025
查看更多
持股ETF
更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
Harbor Health Care ETF
17.71%
American Century Focused Dynamic Growth ETF
2.8%
AdvisorShares Dorsey Wright ADR ETF
2.62%
Virtus LifeSci Biotech Products ETF
1.89%
Tema Heart & Health ETF
1.45%
ProShares Ultra Nasdaq Biotechnology
1.2%
Invesco Nasdaq Biotechnology ETF
1.19%
First Trust Innovation Leaders ETF
1.18%
Putnam Sustainable Future ETF
1.11%
Main Thematic Innovation ETF
1.07%
查看更多
Harbor Health Care ETF
占比17.71%
American Century Focused Dynamic Growth ETF
占比2.8%
AdvisorShares Dorsey Wright ADR ETF
占比2.62%
Virtus LifeSci Biotech Products ETF
占比1.89%
Tema Heart & Health ETF
占比1.45%
ProShares Ultra Nasdaq Biotechnology
占比1.2%
Invesco Nasdaq Biotechnology ETF
占比1.19%
First Trust Innovation Leaders ETF
占比1.18%
Putnam Sustainable Future ETF
占比1.11%
Main Thematic Innovation ETF
占比1.07%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
常见问题
Ascendis Pharma A/S的前五大股东是谁？
Ascendis Pharma A/S 的前五大股东如下：
RA Capital Management, LP持有股份：10.28M，占总股份比例：16.88%。
Westfield Capital Management Company, L.P.持有股份：5.45M，占总股份比例：8.95%。
Avoro Capital Advisors LLC持有股份：4.98M，占总股份比例：8.18%。
Janus Henderson Investors持有股份：4.43M，占总股份比例：7.27%。
Fidelity Management & Research Company LLC持有股份：4.18M，占总股份比例：6.86%。
RA Capital Management, LP持有股份：10.28M，占总股份比例：16.88%。
Westfield Capital Management Company, L.P.持有股份：5.45M，占总股份比例：8.95%。
Avoro Capital Advisors LLC持有股份：4.98M，占总股份比例：8.18%。
Janus Henderson Investors持有股份：4.43M，占总股份比例：7.27%。
Fidelity Management & Research Company LLC持有股份：4.18M，占总股份比例：6.86%。
Ascendis Pharma A/S的前三大股东类型是什么？
Ascendis Pharma A/S 的前三大股东类型分别是：
RA Capital Management, LP
Westfield Capital Management Company, L.P.
Avoro Capital Advisors LLC
RA Capital Management, LP
Westfield Capital Management Company, L.P.
Avoro Capital Advisors LLC
有多少机构持有Ascendis Pharma A/S(ASND)的股份？
截至2025Q4，共有523家机构持有Ascendis Pharma A/S的股份，合计持有的股份价值约为68.62M，占公司总股份的116.45%。与2025Q3相比，机构持股有所增加，增幅为4.06%。
哪个业务部门对Ascendis Pharma A/S的收入贡献最大？
在FY2025Q2，Commercial sale of products业务部门对Ascendis Pharma A/S的收入贡献最大，创收153.66M，占总收入的97.23%。
